本页面由Tiger Trade Technology Pte. Ltd.提供服务

Psyence Biomedical Ltd

2.56
-0.0700-2.66%
盘后2.560.00000.00%19:43 EDT
成交量:1.24万
成交额:3.18万
市值:261.68万
市盈率:-0.07
高:2.63
开:2.50
低:2.50
收:2.63
52周最高:74.94
52周最低:1.92
股本:102.22万
流通股本:97.07万
量比:0.94
换手率:1.27%
股息:- -
股息率:- -
每股收益(TTM):-34.7817
每股收益(LYR):32.76
净资产收益率:-74.29%
总资产收益率:-34.44%
市净率:0.22
市盈率(LYR):0.08

数据加载中...

2024/10/02

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/08/27

SEC问询函

Form CORRESP - Correspondence
2024/08/20

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/07/31

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/07/27

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/05/13

SEC问询函

Form CORRESP - Correspondence
2024/05/10

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/09

SEC问询函

Form CORRESP - Correspondence
2024/05/07

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/06

SEC问询函

Form CORRESP - Correspondence
2024/04/18

SEC问询函

Form CORRESP - Correspondence
2024/04/18

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/02/10

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/02/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/01/31

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/01/23

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/01/17

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/11/15

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/11/13

SEC问询函

Form CORRESP - Correspondence